Clinical Trial Update: Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples

View source ↗

Summary

Completed clinical trial analysis of oncogenes in tumor tissue from patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Intrahepatic Cholangiocarcinoma
• Mixed Hepatocellular-cholangiocarcinoma

Snippet

Sponsor: ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | Conditions: Intrahepatic Cholangiocarcinoma, Mixed Hepatocellular Cholangiocarcinoma | Status: COMPLETED